Area of research
Pulmonary and Respiratory Medicine · Surgery
Research interest
Research interests include Prostate Cancer Diagnosis and Treatment, Prostate Cancer Treatment and Research, Bladder and Urothelial Cancer Treatments, and Advanced Radiotherapy Techniques.
Survival Outcomes and Temporal Trends of Non-Surgical Management Vs Radical Cystectomy in Non-Organ-Confined Urothelial Bladder Cancer
Current Standards for Training in Robot-assisted Surgery and Endourology: A Systematic Review
Adverse In-Hospital Outcomes after Radical Prostatectomy in Leukemia History Patients
Survival after trimodal therapy in octogenarians with organ‐confined urothelial bladder cancer
Prostate-Specific Antigen Level at the Time of Salvage Therapy After Radical Prostatectomy for Prostate Cancer and the Risk of Death
Assessing the Impact of Positive Surgical Margins on Mortality in Patients Who Underwent Robotic Radical Prostatectomy: 20 Years’ Report from the EAU Robotic Urology Section Scientific Working Group
Automated <scp>Ki</scp>‐67 labeling index assessment in prostate cancer using artificial intelligence and multiplex fluorescence immunohistochemistry
Development and External Validation of a Machine Learning Model for Prediction of Lymph Node Metastasis in Patients with Prostate Cancer
Prostate Cancer–specific and All-cause Mortality After Robot-assisted Radical Prostatectomy: 20 Years’ Report from the European Association of Urology Robotic Urology Section Scientific Working Group
PITX1 Is a Regulator of TERT Expression in Prostate Cancer with Prognostic Power
Postoperative Radiotherapy of Prostate Cancer: Adjuvant versus Early Salvage
Overall Survival After Systemic Treatment in High-volume Versus Low-volume Metastatic Hormone-sensitive Prostate Cancer: Systematic Review and Network Meta-analysis
Overall survival and adverse events after treatment with darolutamide vs. apalutamide vs. enzalutamide for high-risk non-metastatic castration-resistant prostate cancer: a systematic review and network meta-analysis
Options for Curative Treatment of Localized Prostate Cancer
Kann die Progression eines Prostatakarzinoms während Active Surveillance durch serielle Magnetresonanztomographie verlässlich diagnostiziert werden?
Long-term Outcomes of Salvage Lymph Node Dissection for Nodal Recurrence of Prostate Cancer After Radical Prostatectomy: Not as Good as Previously Thought
Intermediate-risk Prostate Cancer: Stratification and Management
Objective assessment of intraoperative skills for robot‐assisted radical prostatectomy (RARP): results from the ERUS Scientific and Educational Working Groups Metrics Initiative
Underestimation of Positron Emission Tomography/Computerized Tomography in Assessing Tumor Burden in Prostate Cancer Nodal Recurrence: Head-to-Head Comparison of <sup>68</sup> Ga-PSMA and <sup>11</sup> C-Choline in a Large, Multi-Institutional Series of Extended Salvage Lymph Node Dissections
Correction to: The natural course of pT2 prostate cancer with positive surgical margin: predicting biochemical recurrence
Persistent Prostate-Specific Antigen After Radical Prostatectomy and Its Impact on Oncologic Outcomes
Effect of Extended Pelvic Lymph Node Dissection on Oncologic Outcomes in Patients with D'Amico Intermediate and High Risk Prostate Cancer Treated with Radical Prostatectomy: A Multi-Institutional Study
Expression of CCCTC‐binding factor (CTCF) is linked to poor prognosis in prostate cancer
Impact of Adherence to Multidisciplinary Recommendations for Adjuvant Treatment in Radical Prostatectomy Patients With High Risk of Recurrence
Molecular Evolution of Early-Onset Prostate Cancer Identifies Molecular Risk Markers and Clinical Trajectories
How can we expand active surveillance criteria in patients with low‐ and intermediate‐risk prostate cancer without increasing the risk of misclassification? Development of a novel risk calculator
Loss of CCAAT‐enhancer‐binding protein alpha (CEBPA) is linked to poor prognosis in <i>PTEN</i> deleted and <i>TMPRSS2:ERG</i> fusion type prostate cancers
Adjuvant and Salvage Radiotherapy after Radical Prostatectomy in Prostate Cancer Patients
Low-risk Prostate Cancer: Identification, Management, and Outcomes
Trends in Radical Prostatectomy Risk Group Distribution in a European Multicenter Analysis of 28 572 Patients: Towards Tailored Treatment